PDCD1 and neoplasm: Importantly, using genetically engineered mice, selective deletion of Nhe1 from Cx3cr1+ microglia/myeloid cells elevated CD4+PD-1+ and CD8+PD-1+ tumor infiltration in response to TMZ monotherapy.